MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction

MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction

Background—The identification and stratification of patients at risk of fatal outcomes after myocardial infarction (MI) is of considerable interest to guide secondary prevention therapies. Currently, no accurate biomarkers are available to identify subjects who are at risk of suffering acute manifes...

Full description

Bibliographic Details
Main Authors:	Meyer Elbaz, Julien Faccini, Clémence Laperche, Marie-Hélène Grazide, Jean-Bernard Ruidavets, Cécile Vindis
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Biomolecules
Subjects:	microRNA biomarker myocardial infarction cardiovascular disease
Online Access:	https://www.mdpi.com/2218-273X/12/9/1243

Similar Items

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
by: Pernille Bækgaard Udesen1, et al.
Published: (2020-12-01)

Association between expression level of the miR-320, miR-182, miR-223 and miR-486 and body composition among young Polish female volleyball players
by: Paulina Pruszkowska, et al.
Published: (2024-07-01)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01)

Expression Levels of miR-30c and miR-186 in Adult Patients with Membranous Glomerulonephritis and Focal Segmental Glomerulosclerosis
by: Hejazian SM, et al.
Published: (2020-08-01)

Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors
by: M. S. Knyazeva, et al.
Published: (2022-03-01)

Diagnostic performance of miR-21, miR-124, miR-132, and miR-200b serums in post-stroke cognitive impairment patients
by: Mei Yuan, et al.
Published: (2022-06-01)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01)

Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors
by: Abbas Mosapour, et al.
Published: (2020-08-01)

Circulating microRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the Great East Japan Earthquake
by: Ryosuke Fujii, et al.
Published: (2019-12-01)

Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease
by: Lorenzo Agostino Citterio, et al.
Published: (2023-05-01)

miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway
by: Swati Valmiki, et al.
Published: (2020-01-01)

Expression of miR-145, miR-146, and miR-155 in an experimental model of arteriovenous fistula
by: Hugo Laparra-Escareño, et al.
Published: (2022-01-01)

Methylation of <it>miR-34a, miR-34b/c</it>, <it>miR-124-1 </it>and <it>miR-203 </it>in Ph-negative myeloproliferative neoplasms
by: Chim Chor Sang, et al.
Published: (2011-11-01)

Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy
by: Paweł Rubiś, et al.
Published: (2019-11-01)

Clinical Variables Influence the Ability of miR-101, miR-150, and miR-21 to Predict Ventricular Remodeling after ST-Elevation Myocardial Infarction
by: Liana Maries, et al.
Published: (2023-10-01)

Associations between microRNA (miR-25, miR-32, miR-125, and miR-222) polymorphisms and recurrent implantation failure in Korean women
by: Jeong Yong Lee, et al.
Published: (2019-12-01)

Evaluation of the clinical value of circulating miR-101, miR-187 and miR-21 in neonatal sepsis diagnosis and prognosis
by: Rabab F. Salim, et al.
Published: (2020-03-01)

Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202
by: Ali Gheysarzadeh, et al.
Published: (2018-01-01)

Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221, and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in a Diabetic Alcoholic Murine Model
by: Ricardo Brianezi Tiraboschi, MD, PhD, et al.
Published: (2021-04-01)

miR-221, miR-650 and miR-4534 as diagnostic markers in prostate cancer and their relationship with lymphatic invasion
by: Hekımler Öztürk Kuyaş, et al.
Published: (2022-03-01)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
by: Elena Coccia, et al.
Published: (2020-12-01)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
by: Paulina López, et al.
Published: (2018-05-01)

Exosomal let-7e, miR-21-5p, miR-145, miR-146a and miR-155 in Predicting Antidepressants Response in Patients with Major Depressive Disorder
by: Yi-Yung Hung, et al.
Published: (2021-10-01)

Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines
by: Koo Sunwoo, et al.
Published: (2012-04-01)

MicroRNA molecular profiling reveals increase expression of hsa-miR-186-5p, hsa-miR-320a-3p, and hsa-miR-486-5p with storage time in packed blood cells
by: AbdulFattah Fararjeh, et al.
Published: (2023-01-01)

Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
by: Tatiana Petrova, et al.
Published: (2024-02-01)

Potential role of miR-9 and miR-223 in recurrent ovarian cancer
by: McGuinness Eamonn, et al.
Published: (2008-04-01)

Dysregulation of MiR-21, MiR-221 and MiR-451 During Neoadjuvant Treatment of Breast Cancer: A Prospective Study
by: Carine Bispo Patury, et al.
Published: (2024-12-01)

Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
by: Xulei Huo, et al.
Published: (2023-11-01)

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
by: Dorota Jesionek-Kupnicka, et al.
Published: (2019-03-01)

Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.
by: Xi Zeng, et al.
Published: (2012-01-01)

Fecal miR‐223 is a noninvasive biomarker for estimating Crohn's disease activity
by: Juanjuan Zhang, et al.
Published: (2023-12-01)

miR-1, miR-133a, miR-29b and skeletal muscle fibrosis in chronic limb-threatening ischaemia
by: Alan J. Keane, et al.
Published: (2024-11-01)

miR-16-5p, miR-21-5p, and miR-155-5p in circulating vesicles as psoriasis biomarkers
by: Carlos A. Guzmán-Martín, et al.
Published: (2025-02-01)

miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
by: Adriana Solis-Vivanco, et al.
Published: (2022-09-01)

MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
by: Sunyoung Park, et al.
Published: (2017-09-01)

MiR-223 or miR-126 predicts resistance to dual antiplatelet therapy in patients with ST-elevation myocardial infarction
by: Xiaojing Li, et al.
Published: (2021-06-01)

Plasma miR-153 and miR-223 Levels as Potential Biomarkers in Parkinson’s Disease
by: Li Wu, et al.
Published: (2022-05-01)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors.
by: Teresa Hellberg, et al.
Published: (2020-01-01)

Down regulation of miR‐218, miR‐124, and miR‐144 relates to Parkinson's disease via activating NF‐κB signaling
by: Rui‐Xian Xing, et al.
Published: (2020-10-01)